Sarah Weckhuysen
Antwerpen, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 166 publications
Add-on treatment with vinpocetine reduces seizure frequency and improves comorbidities in patients with loss-of-function γ-aminobutyric acid type A receptor variants.
Journal: Epilepsia
Published: February 03, 2026
Correction: GRIN2A null variants confer a high risk for early-onset schizophrenia and other mental disorders and potentially enable precision therapy.
Journal: Molecular psychiatry
Published: January 07, 2026
Early sodium channel blocker initiation is associated with better outcomes in KCNQ2 disorders.
Journal: Brain : a journal of neurology
Published: October 17, 2025
Bi-allelic variants in FSD1L cause a neurodevelopmental disorder overlapping with L1 syndrome.
Journal: American journal of human genetics
Published: August 13, 2025
Kv7.2 loss-of-function causes early hyperexcitability and network remodelling.
Journal: Brain : a journal of neurology
Published: July 24, 2025
KV7.2 channel dysfunction delays neuronal maturation and undermines early network development in a hiPSC model of KCNQ2-DEE.
Journal: Neurobiology of disease
Published: June 18, 2025
Budget impact analysis of cenobamate, a novel adjunctive therapy for the treatment of drug resistant focal onset seizures, from the Belgian healthcare payer perspective.
Journal: Journal of medical economics
Published: June 17, 2025
Imaging brain development in a KCNQ2-developmental and epileptic encephalopathy mouse model: identifying early biomarkers for functional and structural brain changes.
Journal: EBioMedicine
Published: June 13, 2025
Last Updated: 09/26/2026